Moreover, the KM plot through the TCGA cohort demonstrated that PAAD patients with a higher risk score had poor overall survival, and high expression of STAU2, DDX60L, MRPS10, PARN, and TLR3 was also associated with worse overall survival (Figure 1D, p < 0.01). This evidence concerns the gene STAU2 and pancreatic adenocarcinoma.